Themis Medicare Limited has announced a key management change with the resignation of its Company Secretary and Compliance Officer. The pharmaceutical company informed the stock exchanges about this corporate development under regulatory disclosure requirements.

Key Personnel Change

Mr. Pradeep M. Chandan has resigned from his position as Company Secretary, Compliance Officer, and Key Managerial Personnel (KMP) of Themis Medicare Limited. The resignation became effective from February 13, 2026.

Regulatory Communication

The company formally communicated this development to both major stock exchanges on February 14, 2026. The notification was sent to BSE Limited (Scrip Code: 530199) and National Stock Exchange of India Limited (Symbol: THEMISMED) under reference number TML/BSE/NSE/2025-26/52.

Official Statement

In his resignation letter dated February 12, 2026, Mr. Chandan stated that he was resigning due to other professional commitments. He requested the Board of Directors to accept his resignation and relieve him from his position with immediate effect. The outgoing Company Secretary expressed sincere gratitude to the management and Board of Directors for their support, guidance, and cooperation during his tenure.

Company Leadership

The resignation notification was signed by Mr. Dinesh S. Patel, Chairman & Director (DIN: 00033273), confirming the company's compliance with regulatory disclosure requirements under Regulation 30. The company will need to appoint a new Company Secretary and Compliance Officer to fill the vacant positions in accordance with regulatory requirements.

Themis Medicare Limited has announced the allotment of 60,000 equity shares under its Employee Stock Option Scheme 2012 (ESOP 2012) on December 11, 2025. The pharmaceutical company's Allotment Committee of the Board of Directors approved this issuance during their meeting held on the same date.

ESOP Allotment Details

The allotment involves equity shares with specific parameters that demonstrate the company's commitment to employee participation in ownership:

The shares were issued to eligible employees upon exercise of options that had vested under the company's established employee stock option framework.

Impact on Share Capital

The allotment has resulted in a measurable increase in the company's equity base:

This represents a modest expansion of the company's share capital structure, reflecting the ongoing implementation of its employee incentive programs.

Regulatory Compliance and Share Characteristics

Themis Medicare has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company filed the required statements with both BSE Limited and National Stock Exchange of India Limited, where its shares are listed under scrip code 530199 and symbol THEMISMED respectively.

The newly allotted equity shares maintain identical characteristics to existing shares. All shares issued under the stock option exercise rank pari-passu with the company's existing equity shares, ensuring uniform rights and privileges for all shareholders.

Company Background

Themis Medicare Limited operates in the pharmaceutical sector with its registered office located at Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi, Gujarat. The company's corporate identification number is L24110GJ1969PLC001590, and it maintains its corporate office in Mumbai. The ESOP scheme under which these shares were allotted was established in 2012 and received in-principle approvals from stock exchanges in January 2013.